Longboard Pharmaceuticals, Inc. Common Stock
LBPH
LBPH was delisted on the 29th of November, 2024.
25 hedge funds and large institutions have $51.5M invested in Longboard Pharmaceuticals, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 2 reducing their positions, and 1 closing their positions.
700% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 1
600% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 2
121% more capital invested
Capital invested by funds: $23.3M → $51.5M (+$28.1M)
39% more funds holding
Funds holding: 18 → 25 (+7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.77M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.1M |
| 3 |
PM
Prosight Management
Dallas,
Texas
|
+$4.4M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$3.66M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
+$1.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$226K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.16K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$36 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Bank of America
Charlotte,
North Carolina
| – | -$36 | -11 | Closed |
|
LBPH Hedge Fund Activity: Q1 2023 in Review
25 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Longboard Pharmaceuticals, Inc. Common Stock (LBPH) for Q1 2023, worth a combined $51.5M — up 121% from $23.3M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new LBPH positions and 1 closed out — a net gain of 7 holders — while 14 added to existing stakes and 2 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $8.77M. The largest seller was T. Rowe Price Associates, cutting an estimated $226K.
- 25 institutional investors held Longboard Pharmaceuticals, Inc. Common Stock (LBPH) as of Q1 2023, up from 18 in Q4 2022.
- Funds reported $51.5M of Longboard Pharmaceuticals, Inc. Common Stock stock for Q1 2023, up 121% quarter-over-quarter.
- 8 funds opened new Longboard Pharmaceuticals, Inc. Common Stock positions in Q1 2023 and 1 closed out, a net change of +7 holders.
- The largest Longboard Pharmaceuticals, Inc. Common Stock buyer in Q1 2023 was Fidelity Investments, an estimated $8.77M added.
- The largest Longboard Pharmaceuticals, Inc. Common Stock seller in Q1 2023 was T. Rowe Price Associates, an estimated $226K sold.
Based on aggregated 13F filings for Q1 2023.